Skip to main content
Top
Published in: Breast Cancer Research 2/2005

01-06-2005 | Poster Presentation

The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells

Authors: RS Muraoka-Cook, C Husted, D Hunter, L Miraglia, HS Earp III

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

Cell proliferation in the mammary epithelium is stimulated in part by EGF receptor activation, while differentiation requires ErbB4/HER4, prolactin and STAT5A [1]. Unlike other EGFR family members, HER4 undergoes ligand-dependent transmembrane domain cleavage, releasing a soluble 80 kDa tyrosine kinase (s80HER4) that localizes to the nucleus; the physiologic relevance of s80HER4 is unknown [2]. Using HC11 mouse mammary cells, we showed that EGF, HB-EGF and prolactin increased STAT5A phosphotyrosine and promoter transactivation, but only HB-EGF and prolactin induced differentiation markers and organization into polarized three-dimensional, lumen-containing structures in Matrigel. Heregulin did not stimulate lumen formation; rather, it increased and disorganized HC11 cell growth. Selective inhibition of ErbB1/ErbB2 activation unmasked heregulin-dependent differentiation and lumen formation. Kinase-dead HER4, or a HER4V675A mutant abolishing transmembrane cleavage, were expressed in HC11 cells. HC11 HER4kd or HER4V675A cells exhibited impaired HB-EGF and prolactin-dependent STAT5A translocation, promoter activation and lactogenic marker induction, indicating that both differentiation pathways need ErbB4 kinase activity and s80HER4 formation. HC11 cells constitutively expressing s80HER4 exhibited basal expression of differentiation markers, increased basal STAT5A activity and three-dimensional lumen formation. These results demonstrate that mammary cell differentiation can be stimulated by HER4 through a process requiring s80HER4 production. …
Literature
1.
go back to reference Long W, Wagner K-U, Lloyd KCK, Binart N, Shillingford JM, Hennighausen L, Jones FE: Impaired differentiation and lactational failure in ErbB4-deficient mammary glands identify ERBB4 as an obligate mediator of Stat5. Development. 2003, 130: 5257-5268. 10.1242/dev.00715.CrossRefPubMed Long W, Wagner K-U, Lloyd KCK, Binart N, Shillingford JM, Hennighausen L, Jones FE: Impaired differentiation and lactational failure in ErbB4-deficient mammary glands identify ERBB4 as an obligate mediator of Stat5. Development. 2003, 130: 5257-5268. 10.1242/dev.00715.CrossRefPubMed
2.
go back to reference Carpenter G: ErbB-4: mechanism of action and biology. Exp Cell Res. 2003, 284: 66-77. 10.1016/S0014-4827(02)00100-3.CrossRefPubMed Carpenter G: ErbB-4: mechanism of action and biology. Exp Cell Res. 2003, 284: 66-77. 10.1016/S0014-4827(02)00100-3.CrossRefPubMed
Metadata
Title
The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells
Authors
RS Muraoka-Cook
C Husted
D Hunter
L Miraglia
HS Earp III
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1124

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine